Diabetes Prevention: The Key To Reducing End-stage Kidney Disease
Sep 1, 2020
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Peter Jay Won, Pharm.D. Candidate, University of South Florida, Taneja College of Pharmacy
Earlier onset of type 2 diabetes equals higher risk of kidney transplant.
More than one in three Americans are projected to develop diabetes by 2050. One-in-three of those patients with diabetes will develop end-stage kidney disease (ESKD). ESKD is a $36 billion (2017), or nearly $80,000 annually per person, complication that often requires a transplant and life-long medication support. Unfortunately, there are only a few researchers dedicated to discovering the association between patients with diabetes and their long-term risk of ESKD development. Funding and collecting enough participants are common limiting factors....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.